OncoLink Cancer Treatment and Resources
Link to OncoLink

Screening Mammography and Radiation Exposure

Ultima Vez Modificado: 13 de noviembre del 2005

Question

Dear OncoLink "Ask The Experts,"
My mother was diagnosed with breast cancer at 44 years old. As a result of this, I have been having routine mammograms annually since age 30 (I am currently 37). Am I doing more harm than good by doing this in terms of the long-term radiation exposure? Thank you.

Answer

Lawrence J. Solin, MD, FACR, Professor of Radiation Oncology at the University of Pennsylvania, responds:

Routine screening for the early detection of breast cancer in the asymptomatic patient includes three components: 1) monthly breast self- examination by the patient, 2) physical examination once or twice yearly by a physician, and 3) bilateral mammography. Screening mammography is typically started at age 40, but can be considered at a younger age for the high-risk patient, typically one who has a strongly positive family history or proven genetic risk from a BRCA1 or BRCA2 gene mutation. The age at which mammographic screening is started is a decision that must be based on the potential risk in the individual patient, in order to maximize the risk-benefit ratio. The potential for radiation to induce a malignancy secondary to mammographic screening is very small, and is typically far outweighed by the potential benefit of early detection of a breast malignancy.

Early detection in the high-risk patient may be improved through the use of alternative imaging modalities, in particular, magnetic resonance imaging (MRI) of the breast. MRI is a method of imaging the breast that does not involve radiation, and is used in conjunction with mammography for imaging the breast. Early studies suggest that MRI may increase the yield for detecting early breast cancer in the high-risk patient. When indicated, MRI should be used in addition to, not instead of, screening mammography.

OncoLink I wish u knew...

Dr. Mao discusses why a patient’s culture plays an important role in treatment decisions. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS